Loading
Latest filing published 11 Jul 2022 for Angion Biomedica Corp., €34k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Itzhak Goldberg appears in our data through filings on Elicio Therapeutics, Inc. shares, published by SEC (Form 4). Between 24 June 2021 and 1 July 2022, the trades on record add up to 4 filings.
Sales make up the whole of the open-market record (2 sales, €217k). Other entries cover 2 share grants.
The newest entry dates from 11 July 2022: a share grant of €34k, in Elicio Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 6 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations